Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey
M Wang, J Zhu, DM Lubman, C Gao - Clinical Chemistry and …, 2019 - degruyter.com
Glycosylation is among the most important post-translational modifications for proteins and
is of intrinsic complex character compared with DNAs and naked proteins. Indeed, over 50 …
is of intrinsic complex character compared with DNAs and naked proteins. Indeed, over 50 …
Glycoproteomic markers of hepatocellular carcinoma‐mass spectrometry based approaches
Hepatocellular carcinoma (HCC) is the third most‐common cause of cancer‐related death
worldwide. Most cases of HCC develop in patients that already have liver cirrhosis and have …
worldwide. Most cases of HCC develop in patients that already have liver cirrhosis and have …
Study of serum microRNA19a and microRNA223 as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma
FAF Elmougy, RA Mohamed, MM Hassan, SM Elsheikh… - Gene Reports, 2019 - Elsevier
Background Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor
worldwide and the third leading cause of cancer related death. miRNAs are 19-to 25 …
worldwide and the third leading cause of cancer related death. miRNAs are 19-to 25 …
Clinical features and diagnosis of hepatocellular carcinoma
JM Schwartz, RL Carithers Jr, CB Sirlin… - Waltham …, 2019 - uptodate.com
Hepatocellular carcinoma (HCC) is a primary tumor of the liver that usually develops in the
setting of chronic liver disease, particularly in patients with cirrhosis due to alcohol use …
setting of chronic liver disease, particularly in patients with cirrhosis due to alcohol use …
Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma
KH Kim, JY Kim, JS Yoo - Expert review of proteomics, 2019 - Taylor & Francis
Introduction: Diagnosis of hepatocellular carcinoma (HCC) is important for improving the
survival rate and selecting the optimum therapeutic option. However, some patients with …
survival rate and selecting the optimum therapeutic option. However, some patients with …
应用液态悬浮芯片技术建立肝癌血清标志物蛋白GP73 的检测方法.
吴云， 王一鹏， 马杰， 张永宏， 孙焕芹… - Chinese Journal of …, 2019 - search.ebscohost.com
目的构建高尔基体糖蛋白73 (GP73) 的液态芯片检测体系并评价其检测性能. 方法制备并纯化5
株抗GP73 的单克隆抗体, 采用酶联免疫吸附试验双抗夹心法进行抗体配对筛选 …
株抗GP73 的单克隆抗体, 采用酶联免疫吸附试验双抗夹心法进行抗体配对筛选 …
Development and Analytical Validation of Clinical Assay for AFP, AFP-L3 and PIVKA-II using Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS)
A Sohn - 2019 - s-space.snu.ac.kr
Introduction: Alpha-fetoprotein (AFP), lens culinaris agglutinin-reactive fraction of alpha-
fetoprotein (AFP-L3) protein induced by vitamin K absence or antagonist-II (PIVKA-II) are …
fetoprotein (AFP-L3) protein induced by vitamin K absence or antagonist-II (PIVKA-II) are …
[图书][B] Development of lectins for cancer-specific fucosylation
H Herrera - 2019 - search.proquest.com
Abstract Changes in serum glycosylation have long been associated with hepatocellular
carcinoma (HCC), and these modifications are often detected with sugar-binding proteins …
carcinoma (HCC), and these modifications are often detected with sugar-binding proteins …
[PDF][PDF] Bioscience Research
T Nisar, H Iftikhar, S Azhar, A Ijaz, A Amjad, H Ahmad… - isisn.org
Food choices made by athletes impact their nutritional status, their fitness stability and
effectiveness of their performance on an event. When contrasted to some of the other …
effectiveness of their performance on an event. When contrasted to some of the other …